Repositioning compounds from cancer drug discovery to IPF: PI3K inhibition

Thorax. 2016 Aug;71(8):675-6. doi: 10.1136/thoraxjnl-2016-208680. Epub 2016 Jun 15.
No abstract available

Keywords: Idiopathic pulmonary fibrosis; Lung Cancer.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents
  • Drug Repositioning*
  • Humans
  • Idiopathic Pulmonary Fibrosis
  • Lung Neoplasms
  • Phosphatidylinositol 3-Kinases*

Substances

  • Antineoplastic Agents
  • Phosphatidylinositol 3-Kinases